Hormonal
Prolonged sleep deficiency (short duration or disturbance) causes chronic, systemic low-grade inflammation, which is associated with increased risk of inflammatory diseases such as diabetes, atherosclerosis, and neurodegeneration.
Prioritize consistent, sufficient sleep duration and quality. Chronic sleep loss is not just about feeling tired; it actively drives systemic inflammation, increasing your risk for diabetes, heart disease, and neurodegeneration. Treat sleep as a non-negotiable pillar of immune health, equal in importance to nutrition and exercise.
This notion is supported by findings that prolonged sleep deficiency (e.g., short sleep duration, sleep disturbance) can lead to chronic, systemic low-grade inflammation and is associated with various diseases that have an inflammatory component, like diabetes, atherosclerosis, and neurodegeneration.
Why this rating
The paper is a comprehensive review citing numerous experimental, laboratory, and field studies, though it notes methodological challenges and lack of consistent definitions for low-grade inflammation.
Source
The Sleep-Immune Crosstalk in Health and Disease
Luciana Besedovsky et al. · Physiological Reviews · 2019
DOI 10.1152/physrev.00010.2018
More from this paper
- Adequate sleep enhances host defense by improving infection outcomes and vaccination responses, mediated by the induction of a hormonal constellation that supports immune functions.Good
- Immune system activation (e.g., by microbial challenges) triggers an inflammatory response that increases sleep duration and intensity, serving as a homeostatic regulation of slow-wave sleep.Good
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →